Patent Application Titled "High Concentration Antibody Formulations" Published Online (USPTO 20240191000).

A patent application titled "High Concentration Antibody Formulations" has been published online by the US Patent and Trademark Office. The patent application, filed by inventors Nien-Yi Chen and Wei-Ting Kao, and assigned to Oneness Biotech Co. Ltd., describes the development of antibody formulations with high concentrations of biologic molecules. These formulations show superior stability and injectability and may be used in the treatment of disorders associated with immunoglobulin E (IgE), such as allergic asthma, allergic rhinitis, atopic dermatitis, or hyper IgE syndrome. The antibody formulations consist of specific concentrations of antibodies, histidine, amino acids (arginine or threonine), sodium chloride, and polysorbate 80. [Extracted from the article]